Guideline recommends antiviral prophylaxis for patients at high risk for HBV reactivation

Ann Intern Med. 2025 May;178(5):JC50. doi: 10.7326/ANNALS-25-01453-JC. Epub 2025 May 6.

Authors

Sana A Pirzada¹, Averell H Sherker²; ACP Journal Club Editorial Team at McMaster University

Affiliations

¹ Division of Hospital Medicine, Washington University School of Medicine, St. Louis, Missouri, USA (S.A.P.).
² Liver Disease Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA (A.H.S.).

PMID: 40324189
DOI: 10.7326/ANNALS-25-01453-JC

Abstract

GIM/FP/GP: [Formula: see text] Gastroenterology: [Formula: see text] Infectious Disease: [Formula: see text] Public Health: [Formula: see text].